Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05589415 · ClinicalTrials.gov registry record · NA

Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI

A NA study of Spinal Cord Injuries and Spinal Cord Diseases, sponsored by University of Texas Rio Grande Valley.

Active
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05589415: Active NA study of Spinal Cord Injuries and Spinal Cord Diseases, sponsored by University of Texas Rio Grande Valley.

NCT05589415 is a NA study of Spinal Cord Injuries and Spinal Cord Diseases that is active but no longer recruiting, run by University of Texas Rio Grande Valley. The registered enrollment target is 24 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05589415, a NA study of Spinal Cord Injuries and Spinal Cord Diseases, is active but no longer recruiting, sponsored by University of Texas Rio Grande Valley.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The proposed project seeks to maximize the functional recovery achieved during the rehabilitation of the paretic upper limbs in individuals with SCI. The investigation will work towards optimizing the use of transcranial direct current stimulation (tDCS), an adjunct known to improve the effectiveness of rehabilitation. In particular, the relationship between the specificity of current delivery and functional benefit will be explored, and findings may lead to a framework that can be translated to the clinic setting.

Primary Outcome

Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) is a clinical tool that incorporates assessment of both upper limb motor function and activity limitations (9 hole peg test, grasping). The Investigators will assess the changes in movement control from Baseline, 2 weeks, and after four weeks of rehabilitation. An increase in time spent completing the peg test and grasping test signifies an increase in a participant's performance of strength, sensibility, and prehensio

Interventions

  • DEVICE High-definition Transcranial Direct Current Stimulation
  • DEVICE Conventional Transcranial Direct Current Stimulation

Study Locations (1)

Texas

  • University of Texas Rio Grande Valley - Harlingen

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2020-11-23
Est. Completion 2026-05-23
Phase NA

What the registry record for NCT05589415 still lists

NCT05589415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (61% lower).

The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which High-definition Transcranial Direct Current Stimulation is the first listed.

NCT05589415 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05589415 about?

NCT05589415 is a clinical study titled "Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI". The proposed project seeks to maximize the functional recovery achieved during the rehabilitation of the paretic upper limbs in individuals with SCI. The investigation will work towards optimizing the use of transcranial direct current stimulation (tDCS), an adjunct known to improve the effectivenes...

What is the current status of trial NCT05589415?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2020-11-23. Estimated completion is 2026-05-23.

What conditions does trial NCT05589415 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Spinal Cord Diseases.

What interventions are being tested in trial NCT05589415?

The interventions under investigation include: High-definition Transcranial Direct Current Stimulation (DEVICE), Conventional Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05589415?

This trial is sponsored by University of Texas Rio Grande Valley, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05589415 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05589415's enrollment target sits among peer trials

24 114th of 202 higher than 82 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05589415, the US trial registry maintained by the National Library of Medicine. NCT05589415 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.